Division of Pharmaceutical Analysis, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993.
Division of Liquid Based Products, Office of Lifecycle Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993.
J Pharm Sci. 2019 Feb;108(2):815-820. doi: 10.1016/j.xphs.2018.09.027. Epub 2018 Oct 3.
In a typical oil-in-water emulsion drug product, oil droplets with varied sizes are dispersed in a water phase and stabilized by surfactant molecules. The size and polydispersity of oil droplets are critical quality attributes of the emulsion drug product that can potentially affect drug bioavailability. More critically, to ensure accuracy in characterization of the finished drug product, analytical methods should introduce minimal physical perturbation (e.g., temperature variation or dilution) before the analysis. The classical methods of dynamic light scattering or electron microscopy can be used but they generally require sample dilution or harsh preparation conditions, respectively. By contrast, the size distribution of emulsion formulations can be assessed with a simple and noninvasive solution nuclear magnetic resonance method, namely, two-dimensional Diffusion Ordered SpectroscopY. The two-dimensional Diffusion Ordered SpectroscopY method probed signal decay of methyl resonances from oil and sorbate molecules and was applied to 3 types of U.S.-marketed emulsion drug products, that is, difluprednate, cyclosporine, and propofol, yielding measured droplet sizes of 40-280 nm in diameter. The high precision of ±6 nm of the new nuclear magnetic resonance method allows analytical differentiation of lot-to-lot and brand-to-brand droplet size differences in emulsion drug products, critical for drug-quality development, control, and surveillance.
在典型的油包水乳状药物产品中,大小不同的油滴分散在水相中,并由表面活性剂分子稳定。油滴的大小和多分散性是乳状药物产品的关键质量属性,可能会影响药物的生物利用度。更关键的是,为了确保对成品药物的准确描述,分析方法应在分析前引入最小的物理干扰(例如温度变化或稀释)。可以使用经典的动态光散射或电子显微镜方法,但它们通常分别需要样品稀释或苛刻的制备条件。相比之下,可以使用简单且非侵入性的溶液核磁共振方法(即二维扩散有序光谱法)评估乳剂制剂的粒径分布。二维扩散有序光谱法探测来自油和吸附剂分子的甲基共振信号的衰减,并应用于 3 种美国市售乳剂药物产品,即双氟泼尼酯、环孢素和丙泊酚,得出直径为 40-280nm 的测量油滴粒径。新的核磁共振方法的高精度为±6nm,允许对乳状药物产品中的批间和品牌间的粒径差异进行分析区分,这对于药物质量的开发、控制和监测至关重要。